First read
“Peptide therapy” sounds like one kind of care. It is not. Sort the offer into the right lane before judging the promise.
Start with the label
All the word tells you is the chemistry inside. It says nothing about whether a product was reviewed, whether a pharmacy made it, or whether a seller is making unsupported claims.
Lane one
The generic name is the ingredient. A brand name is the product name. Say both the first time so there is no confusion.
FDA-approved medicines in the United States, as of September 2026, count semaglutide, sold as Ozempic and Wegovy, among them, and tirzepatide, sold as Mounjaro and Zepbound, sits on that list as well.
Claim source: Drugs@FDA application records, summarized in CA-lanes-02 and CA-lanes-03.
Approval covers one exact product for one exact use. A different ingredient, a different form (such as a pill instead of a shot) or a different purpose needs its own review. A familiar name on a web page is not enough.
Lane two
Rather than handing over a factory-made product, a pharmacist or doctor mixes the medicine for one patient. This can fill a real medical need, but it is a different route from approval.
Compounded medicines carry no FDA approval, and nobody at the FDA checks their safety, effectiveness or quality ahead of sale.
Claim source: FDA compounding questions and answers, summarized in CA-compounding-02.
Lane three
A page may pair that label with claims about weight, healing or hormones. Read the whole offer, not the small print.
As of September 2026, the FDA’s warning letters make the point that printing “research use only” on a product meant for people does not make it a legal treatment. A warning letter is a formal notice the FDA sends to a company it believes is breaking federal drug rules.
Claim source: FDA warning letter, summarized in CA-lanes-07.
A page that will mail a vial without a real prescription belongs in the red-flag pile, not the clinic-comparison pile.
Now make it local
Ask for the exact medicine, the person prescribing it and the pharmacy that will fill it. If an answer stays vague, pause the comparison.